This information sheet presents basic information for injecting drug users (IDUs) on disinfection, especially bleach disinfection, of drug injection equipment to reduce the risk of getting or transmitting HIV or HCV.
This report is a white paper outlining the Centers for Disease Control and Prevention’s (CDC) National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention’s (NCHHSTP) vision for program collaboration and service integration (PCSI). The white paper defines and articulates a framework for conceptualizing PCSI. It identifies how NCHHSTP will work with internal and external stakeholders to accomplish the goals; outlines key measures to monitor and evaluate progress; and describes how NCHHSTP will work with partners at national, state, and local levels to advance PCSI.
This study discusses information on the 184 syringe exchange programs (SEPs) operating in 36 states, the District of Columbia, and Puerto Rico. Of these SEPs, 67% completed a mail/telephone survey conducted by North American Syringe Exchange Network (NASEN) and Beth Israel Medical Center, New York, which covered program operations for 2008. The report summarizes findings from the survey and compares them with results from a previous SEP survey for 1994-2007.
This report provides data on the mortality among patients with TB and associations with HIV infection. To investigate the impact of HIV on risk for death during TB treatment in the United States, data were analyzed for all culture-positive patients with TB from 1993 to 2008. The proportion that died was determined and stratified by HIV test result. Mortality data were restricted to patients reported before 2007.
This report presents all 2009 profiles that provide an overview of syphilis morbidity in each of the 50 states, the District of Columbia, Guam, Puerto Rico, and the Virgin Islands. The profiles consist of figures and tables of data on syphilis from the U.S. states and territories through 2009. These data are based on case reports from the 65 sexually transmitted disease (STD) prevention project areas. Case report data are the foundation of STD surveillance systems, and are collected by state and local health departments.
This report provides a summary of responses from a web-based survey of public health laboratories on volume and type of testing for STDs in the United States in 2007. The survey was conducted in 2008. Responses were received from 61.4 percent (94 of 153) participants. In 2007, 3,290,390 chlamydia tests and 3,157,827 gonorrhea tests were performed in the surveyed laboratories; 89.7 percent of chlamydia tests and 84.4 percent of gonorrhea tests were nucleic acid amplification tests. Over 90 percent of responders reported syphilis testing.
This Toolkit is the principal outcome of the second phase of the EPT law project. It is intended as a resource for voluntary use by government officials at the state and local levels, their public and private sector partners, and others who are interested in adopting or facilitating the implementation of statutes or regulations that permit EPT in clinical practice. This Toolkit is not designed to provide specific legal guidance or advice and does not represent the official legal positions of federal, state, or local governments.
This report represents all 2011 profiles that provide an overview of syphilis morbidity in each of the 50 states, the District of Columbia, Guam, Puerto Rico, and the Virgin Islands. The profiles consist of figures and tables of data on syphilis from the U.S. states and territories through 2011. These data are based on case reports from the 65 STDs prevention project areas. Case report data are the foundation of STD surveillance systems, and are collected by state and local health departments.